Please "Login" to See Price.
VPULSE helps patients achieve complete, comfortable recovery through delivery
of three distinct therapies:
•Rapid impulse calf compression to help prevent Deep Vein Thrombosis (DVT)
•Motorized cold therapy to help reduce operative site discomfort and inflammation
•Wound compression to further help reduce operative site inflammation

VPULSE improves patient outcomes, reduces the total cost of the orthopedic episode and increases patient satisfaction to deliver more time well spent. Federal law restricts this device to sale by or on the order of a licensed health care practitioner.
  • Common Examples of Use
  • Features
  • Product Specs

• Lowers Risk of Venous Thromboembolism (VTE)
VPULSE lowers incidence of VTE after major orthopedic surgery compared to pharmacological prophylaxis. VTE is the leading factor for hospital readmission following major orthopedic surgery and the most common preventable cause of hospital death.*
• Provides Possible Alternative to Anticoagulants
VPULSE offers physicians another option to help tailor preventative care to patient risk and provides an alternative for patients contraindicated for anticoagulants.
• Provides Convenient Home Therapy
As hospital stays continue to shorten, VPULSE provides a solution for patients to take home and keep. This allows facilities to offer mechanical DVT prophylaxis for the 2-3 weeks patients need it most, without the hassle of renting or servicing equipment.

• Improves Patient Experience
Combining three therapies into one convenient device optimizes patient comfort during recovery. With motorized cold therapy and accompanying water bottles, patients avoid the hassle of frequently switching out ice cubes or gel packs.
• May Improve Compliance
The added comfort of cold and compression therapies may increase patient compliance compared to DVT prophylaxis alone. A removable data card records patient compliance to enable physician monitoring.
• Lowers Total Cost
Bundled payment of care initiatives are driving single payment for an orthopedic episode within 10 days of surgery, including costly DVT readmissions. By reducing DVT-related expenses and potentially reducing costs for anticoagulant regimens or compression device rental programs, VPULSE helps reduce the total cost of the episode.

* Westrich GH et al. Meta-analysis of thromboembolic prophylaxis after TKA. J Bone Joint Surg Br. 2000 Aug; 82 (6) 795-800. * Snyder MA et al. Efficacy in Deep Vein Thrombosis Prevention with Extended Mechanical Compression Device Therapy and Prophylactic Aspirin Following Total Knee Arthroplasty: A Randomized Control Trial, The Journal of Arthroplasty (2017), doi: 10.1016/j. arth.2016.12.027.